Methionine Restriction Promotes the Polarization of Macrophages Towards M1 and the Immunotherapy Effect of PD-L1/PD-1 Blockades by Inhibiting the Secretion of MIF by Gastric Carcinoma Cells

Lin Xin,Jiang Liu,Jun-Yan Lai,He-Song Xu,Luo-Jun Fan,Yong-Hui Zou,Qi Zhou,Zhen- Qi Yue,Jin-Heng Gan
DOI: https://doi.org/10.1016/j.tranon.2024.102181
IF: 4.803
2024-01-01
Translational Oncology
Abstract:Background The limited curative effect of PD-L1/PD-1 blockades presents challenges to immunotherapy for advanced gastric cancer. We have found that methionine restriction (MR) enhances the drug resistance of gastric carcinoma cells. We aimed to explore whether MR can enhance the efficacy of PD-L1/PD-1 blockades in gastric cancer. Methods To conduct MR, gastric carcinoma cells were transfected with LV-METase in vitro, and 615 mice were injected with MFC cells with stable METase expression in vivo. Flow cytometry was conducted to measure the proportions of M1/M2 macrophages and CD8+ GZMB+/IFN-γ+ T cells. Additionally, the levels of M1/M2 macrophage markers and MIF were also detected. Results MR increased M1 and down-regulated M2 macrophages. MR suppressed MIF levels in gastric carcinoma cells, while the addition of anti-MIF neutralizing antibody inhibited the effect of MR on macrophage M1/M2 polarization. MR enhanced the increase of the proportion of CD8+ GZMB+ T cells and CD8+ IFN-γ+ T cells induced by PD-L1/PD-1 blockades. In vivo detection verified the efficacy of the combination of MR and PD-L1/PD-1 blockades on gastric cancer. Conclusions MR inhibits the secretion of MIF by gastric carcinoma cells, promotes macrophage M1 polarization, and enhances the therapeutic effect of PD-L1/PD-1 blockades in gastric cancer.
What problem does this paper attempt to address?